A study published in Nature reports that danshensu, a compound derived from the herb Danshen, reduces osteoporosis associated with type 2 diabetes. According to Nature, the effect works through the PI3K/AKT/Nrf2 signaling pathway. The findings were published on Sunday, September 27, 2026.
The research points to a specific biological route behind the compound's activity. Nature reports that the PI3K/AKT/Nrf2 pathway is central to how danshensu attenuates the bone condition tied to type 2 diabetes. The headline and summary of the study do not detail the experimental methods, dosages, or whether the work involved animal models or human participants.
Osteoporosis is a known complication in people with type 2 diabetes, a condition in which bone strength can decline even as other metabolic markers are managed. Danshensu comes from Danshen, a traditional herb, and the Nature study frames its potential role specifically around diabetes-related bone loss rather than osteoporosis in general.
